The Eli Lilly and Novo Nordisk logos.
Mike Blake | Tom Little | Reuters
The diverging paths of two GLP-1 drugmakers were on full display this week.
Both Read Entire Article
The Eli Lilly and Novo Nordisk logos.
Mike Blake | Tom Little | Reuters
The diverging paths of two GLP-1 drugmakers were on full display this week.
Both Read Entire Article